A case of feline fibroepithelial hyperplasia in a male cat

Yıl 2020, , 8 - 12, 30.04.2020

Çağla Küçükbekir Zeynep Günay Uçmak , İsmail Kırşan , Çağatay Tek

https://doi.org/10.30704/http-www-jivs-net.691787

Cited By: 2

Öz

A nine-month old, orange tabby, intact male cat was brought to our clinic with the complaint of swelling in the mammary glands. In anamnesis; long acting progesterone was administered to the cat in a private clinic for suppression of oestrus one week ago. As a result of clinical examination, fibroepithelial hyperplasia was detected in all mammary glands. For the purpose of treatment, aglepristone started to be used for sequential five days. Because ulceration and necrosis occurred in the mammary glands at the end of the first week, the treatment was completed with total mastectomy section. In this article, a case of fibroepithelial mammary hyperplasia which was formed as a result of progesterone administration to suppress the oestrus in a male cat is described.

Anahtar Kelimeler

Fibroepithelial hyperplasia, male cat, aglepristone, surgery

Kaynakça

• Allen, H.L. (1973). Feline mammary hypertrophy. Veterinary Pathology, 10, 501– 508.
• Baştan, A., Fındık, M., Erünal, N., Aslan, S., Kılıçoğlu, Ç. (1998). The use of cabergoline for the treatment of pseudopregnancy in dogs with the purpose of suppressing lactation. Reproduction in Domestic Animal, 33, 49-53.
• Bethlehem, M., Van Der Luer, R.J. (1993). Feline fibroepithelial hyperplasia in 3 castrated tomcats following treatment with progestagens. Tijdschrift Voor Diergeneeskunde, 15, 650–652.
• Burstyn, U. (2010). Management of mastitis and abscessation of mammary glands secondary to fibroadenomatous hyperplasia in a primiparturient cat. Journal of the American Veterinary Medical Association, 236: 326–329.
• Chisholm, H. (1993). Massive mammary enlargement in a cat. Canadian Veterinary Journal, 34: 315.
• De Souza, T.M., Fighere, R.A., Langohr, I.M., De Bartos, C.S.L. (2002). Hiperplasia fibroepithelial mamaria em felinos: Cinco casos. Ciencia Rural, 32, 891–894.
• Dolezel, R., Vitasek, R., Senior, D.F. (2001). Disturbances of reproductive system. Small Animal Veterinary Association, 1253–1357.
• Goldschmidt, M., Pena, L., Rasotto. R., Zappulli, V. (2011). Classification and grading of canine mammary tumors. Veterinary Pathology, 48, 117–131.
• Görlinger, S., Kooistra, H.S., Van Den Broek, A., Okkens, AC. (2002). Treatment of fibroadenomatous hyperplasia in cats with aglepristone. Journal of Veterinary Internal Medicine, 16: 710– 713.
• Gültiken, N., Aslan, S., Ay, S.S., Gülbahar, M.Y., Thuróczy, J., Koldaş, E., Kaya, D, Fındık, M., Schäfer Somi, S. (2017). Effect of deslorelin on testicular function, serum dihydrotestosterone and oestradiol concentrations during and after suppression of sexual activity in tom cats. Journal of Feline Medicine and Surgery, 19(2):123-131.
• Hayden, D.W., Johnston, S.D., Kiang, D.T., Johnson, K.H., Barnes, D.M. (1981). Feline mammary hypertrophy fibroadenoma complex: clinical and hormonal aspects. American Journal of Veterinary Research, 42, 1699–1703.
• Hayden, D.W., Barnes, D.M., Johnson, K.H. (1989). Morphologic changes in the mammary gland of megestrol acetatetreated and untreated cats: a retrospective study. Veterinary Pathology, 26: 104–113.
• Hinton, M., Gaskell, C.J. (1977). Non-neoplastic mammary hypertrophy in the cat associated ether with pregnancy or with oral progestagen therapy. Veterinary Record, 100, 277–280.
• Jelinek, F., Barton, R., Posekana, J., Hasonova, L. (2007). Gynaecomastia in a tom-cat caused by cyproterone acetate: a case report. Veterinarni Medicina, 52, 2007 (11): 521–525.
• Johnston, S.D., Kustritz, M.V.R., Olson, P.N.S. (2001). Mammary hypertropy. Canine and feline theriogenology. Philadelphia, PA: Saunders.
• Keskin, A., Yılmazbaş, G., Şimşek, G., İntaş, K.S. (2008). Mammary hyperplasia in a pregnant queen. Australian Veterinary Practitoner, 38, 75.
• Loretti, A.P., Ilha, M.R.S., Breitsameter, I., Faraca, C.S. (2004). Clinical and pathological study of feline mammary fibroadenomatous change associated with depot medroxyprogesterone acetate therapy. Arquivo Brasilero de Medicina Veterinariae Zootecnia, 56(2), 270-274.
• Loretti, AP., Ilha, M.R., Ordas, J., Martin de las Mulas, J. (2005). Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depot medroxyprogesterone acetate. Journal of Feline Medicine Surgery, 7, 43–52.
• MacDougall, L.D. (2003). Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. Canadian Veterinary Journal, 44, 227–229.
• Mandel, M. (1975). Spontaneous remission of feline benign mammary hypertrophy. Veterinary Medicine Small Animal Clinician, 70: 846–847.
• Mayayol, SL., Bo, S., Pisu, M.C. (2018). Mammary fibroadenomatous hyperplasia in a male cat. Journal of Feline Medicine and Surgery Open Reports. doi: 10.1177/2055116918760155.
• Mol, JA., Henzen-Logmans, S.C., Hageman, P., Misdorp, W., Blankenstein, M.A., Rijnberk, A. (1995). Expression of the gene encoding growth hormone in the human mammary gland. The Journal of Clinical Endocrinology and Metabolism, 80: 3094–3096.
• Mol, JA., Van Garderen, E., Rutteman, G.R., Rijnberk, A. (1996). New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. The Journal of Steroid Biochemistry and Molecular Biology, 57: 67–71.
• Nak, D., Nak, Y., İntaş, K.S., Kumru, İ.H. (2004). Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone. Australian Veterinary Practitoner, 34(4), 161-162.
• Özenç, E., Bozkurt, M.F. (2014). Atypical fibroepithelial hyperplasia of the teats in a Sphynx cat: a case report. Article in Veterinární medicína. doi: 10.17221/7521.
• Piyarungsri, K., Tangtrongsup, S., Thitaram, N., Lekklar, P., Kittinuntasilp, A. (2020). Prevalence and risk factors of feline lower urinary tract. Scientific Reports, 10: 196.
• Romagnoli, S., Concannon, P.W. (2003). Clinical use of progestins in bitches and queens: a review. Recent Advances in Small Animal Reproduction. International Veterinary Information Service Ithaca, A1206.0903.
• Uçmak, M., Enginler, S.Ö., Gündüz, M.C., Kırşan, İ., Sönmez, K. (2011). Treatment of Feline Mammary Fibroepithelial Hyperplasia with the Combination of Aglepristone and Cabergoline. Journal of the Faculty of Veterinary Medicine, Istanbul University, 37 (1), 69-73.
• Verstegen, J.P. (1998). Pharmacological control of reproduction in the cat. Manuel of small animal reproduction and neonatology, 219-226.
• Vitasek, R, Dendisova, H. (2006). Treatment of feline fibroepithelial hyperplasia following a single injection of proligestone. Acta Veterinaria Brno, 75, 295-297.
• Wehrend, A., Hospes, R., Gruber, A.D. (2001). Treatment of feline fibroadenomatous hyperplasia with a progesterone antagonist. Veterinary Record, 148, 346-347.
• Zertova, H. (2001). Disorders of behaviour in dogs and cats. Czech Small Animal Veterinary Association, 1645–1679.